StockWatch
·
HomeLiveWeekly

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

BSE: 500660

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
82.02436.44790.851.1KQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
21.3926.8832.3637.85Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue989.15-3.3%1.0K+5.0%973.63+21.0%804.83-16.7%966.08+2.1%946.36-5.4%1.0K
Other Income35.71+12.2%31.82+1.8%31.27-28.5%43.76+10.9%39.46+12.5%35.06+8.9%32.19
Total Income1.0K-2.8%1.1K+4.9%1.0K+18.4%848.59-15.6%1.0K+2.5%981.42-4.9%1.0K
EXPENSES
Expenditure655.74-3.1%676.52+3.0%656.89+15.2%570.02-12.4%650.64-3.6%675.07-3.3%698.23
Tax94.18-6.5%100.71+5.3%95.65+29.5%73.87-22.0%94.76+21.8%77.77-13.6%90.01
PROFIT
PBT369.12-2.3%377.89+7.8%350.65+25.9%278.57-21.5%354.90+15.8%306.35-9.6%338.70
Net Profit274.94-0.8%277.18+8.7%255.00+24.6%204.70-21.3%260.14+13.8%228.58-8.1%248.69
KEY METRICS
OPM %35.10%-0.85pp35.95%+1.30pp34.65%+3.49pp31.16%-3.08pp34.24%+7.57pp26.67%-2.27pp28.94%
NPM %26.83%+0.54pp26.29%+0.91pp25.38%+1.26pp24.12%-1.75pp25.87%+2.58pp23.29%-0.80pp24.09%
EPS16.23-0.8%16.36+9.7%14.92+23.5%12.08-21.3%15.35+13.8%13.49-6.6%14.45

Corporate Events

Board MeetingGLAXO
2026
3Aug

Board Meeting

A meeting of the Board of Directors of our Company will be h…

BSE Filing ↗
Board MeetingGLAXO
2025
1Aug

Board Meeting

Board Meeting Intimation, Un-Audited Financial Results for t…

BSE Filing ↗
Board MeetingGLAXO
2025
14Feb

Board Meeting

Consider and approve Un-audited financial results for the th…

BSE Filing ↗
DividendGLAXO
2024
7Nov

₹12 / share

BSE Filing ↗
Board MeetingGLAXO
2024
29Oct

Board Meeting

consider and approve Unaudited financial results for the sec…

BSE Filing ↗
Board MeetingGLAXO
2024
2Aug

Board Meeting

Consider and approve Un-Audited Financial Results for the fi…

BSE Filing ↗
DividendGLAXO
2024
31May

₹32 / share

BSE Filing ↗
Board MeetingGLAXO
2024
12Feb

Board Meeting

consider and approve Un-Audited Financial Results for the th…

BSE Filing ↗
Board MeetingGLAXO
2023
9Nov

Board Meeting

Consideration and approval of Un-Audited Financial Results f…

BSE Filing ↗